Miwako Kamei
| Faculty of Pharmaceutical Sciences,Department of Pharmaceutical Sciences | Dean of Faculty/Chair of Department/Professor |
| Graduate School of Pharmaceutical Sciences,Doctoral Program in Pharmaceutical Sciences | Dean of Graduate School/Chair of Program/Professor |
Last Updated :2025/10/07
■Researcher basic information
■Career
Career
- Apr. 2020 - Present
Teikyo Heisei University, Faculty of Pharmaceutical Sciences, Professor - Oct. 2010 - Mar. 2020
School of Pharmacy, Nihon University, Professor - 01 Apr. 2006 - 30 Sep. 2010
School of Pharmacy, Showa University, Professor - 01 Apr. 2002 - 31 Mar. 2006
School of Pharmacy, Nihon University, Lecturer - 01 Apr. 1989 - 31 Mar. 2002
School of Pharmacy, Nihon University, Assistant Researcher
Educational Background
■Research activity information
Award
- Oct. 2023
- 03 Nov. 2018
日本薬局学会, 功労賞
Japan society - 24 Nov. 2015
日本私立薬科大学協会, 教育賞
Publisher - Nov. 2013
日本薬局学会, 功労賞
Japan society - Jun. 2013
公益社団法人 日本薬剤師会, 日本薬剤師会創立120周年特別表彰
Others - Jun. 2005
日本医療薬学会, 論文賞
医薬分業下での薬局薬剤師によるファーマシューティカル・ケアの便益の測定, Official journal - Jul. 2001
日本薬剤学会第26回製剤セミナー, Postdoctoral Presentation Award
患者意識からみた保険薬局の評価要因に関する研究, Japan society - Aug. 1999
50th IPSF annual meeting, Pharmaceutical Press Award
Improvement of patients' compliance by "one-dose-package" method, United Kingdom, Publisher
Paper
- Development of the Japanese Anticholinergic Risk Scale: English translation of the Japanese article
Fumihiro Mizokami; Tomohiro Mizuno; Rena Taguchi; Izumi Nasu; Sayaka Arai; Keiichiro Higashi; Ayaka Matsumoto; Miwako Kamei; Taro Kojima; Takayoshi Sakai; Yuuka Shibata; Yasushi Takeya; Masaki Mogi; Shizuo Yamada; Masahiro Akishita
Geriatrics & Gerontology International, 05 Dec. 2024, [Reviewed]
Background
Anticholinergic burden, reflecting the cumulative impact of medications with anticholinergic properties, significantly predicts adverse drug reactions and geriatric syndromes in older adults. Although anticholinergic risk scales (ARS) have been developed and validated in various countries, none have been tailored specifically for Japan. The Japanese Anticholinergic Risk Scale (JARS) was developed to adapt the existing ARS frameworks to the Japanese context, considering unique medication profiles and cultural factors.
Process
First, a systematic review was performed to follow the protocol registered in PROSPERO (CRD42017076510). A PubMed search from October 2017 to March 2023 was conducted to identify ARS publications post‐September 2017. Based on two algorithms, average scores from the existing scores were used to develop JARS. The Delphi method, an expert consensus approach, was applied to determine the scores for medications that were not established by the algorithms. Sixteen articles identified in our systematic review contributed to JARS development. JARS categorizes 158 medications into three potency groups: 37 drugs scored as 3 (strong), 27 as 2 (moderate), and 94 as 1 (weak).
Conclusion
JARS, the newly developed ARS, could be a critical tool for anticholinergic burden assessment in older Japanese populations. Developed through a systematic review and Delphi‐based expert consensus, it encompasses 158 medications, offering a comprehensive anticholinergic burden assessment. Future studies and updates should be conducted to improve the accuracy and clinical applicability of this scale. Geriatr Gerontol Int 2025; 25: 5–13. - Comprehensive Survey of Information-sharing Tools Used between Hospital and Community Pharmacies
Ryohei Suzuki; Misako Jimbo; Tomohiro Mizuno; Yoshitomo Shimazaki; Hisato Fujihara; Akihiro Manaka; Taro Kojima; Yasushi Takeya; Miwako Kamei; Fumihiro Mizokami
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 10 Mar. 2024, [Reviewed] - Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study
Rie Nakajima; Nobuhiro Ooba; Miwako Kamei; Hajime Hashiba; Choichiro Miyazaki
Expert Opinion on Drug Safety, 21 Mar. 2023, [Reviewed] - 保険薬局業務の現状と複数率を指標とした「かかりつけ薬局」の機能評価―2021 年日本薬剤師会全国薬局調査―
Dec. 2022, [Reviewed] - Event Monitoring and Evaluation by Community Pharmacists in Japan: A Pilot Study on Fenofibrate and Pemafibrate
Nobuhiro Ooba; Masao Takahashi; Marina Nagamura; Makoto Ushida; Eiji Kawakami; Masaomi Kimura; Tsugumichi Sato; Yoshinori Takahashi; Junichi Tokuyoshi; Hajime Hashiba; Miwako Kamei; Choichiro Miyazaki; Mitsuaki Shimada
Current Drug Safety, Nov. 2022, [Reviewed]
Background:
The Japan Pharmaceutical Association has conducted drug event monitoringto detect drug events related to pemafibrate. As there are a few studies on the safety of pemafibratein clinical settings, a pilot study evaluating the association between drug use and detectedevents was performed in Japan.
Aim:
In this study, the association between detected events and the use of pemafibrate, utilizingpharmacy records maintained by community pharmacists, was investigated. We identified the newusercohort using a test and active comparison drug and collected the baseline information. An activecomparison group comprising new users was used to assess the events.
Method:
A retrospective cohort study using questionnaires regarding baseline and event data wasconducted by community pharmacists belonging to the Japan Pharmaceutical Association. The incidenceof event and estimated hazard ratio were calculated using the Cox proportional hazardsmodel that was adjusted for confounding factors, such as age and sex.
Results:
A total of 1294 patients using pemafibrate and 508 patients using fenofibrate were identifiedas new drug users. The most reported events involving suspected adverse reactions and add-ondrugs were increased blood pressure and lipid-lowering effects with pemafibrate use, and nasopharyngitis,pruritus, dizziness, and lipid-lowering effects with fenofibrate use. No significant differenceswere found in commonly occurring events, except that an add-on anti-hypertensive drughas been used by pemafibrate users compared to fenofibrate users.
Conclusion:
This study conducted by pharmacists can facilitate the safety assessment of newlymarketed drugs, as few drug use investigations with a comparator are carried out by the Japaneseauthority for pharmaceutical companies. However, further research is required. - 医療的ケア児に対する薬学的ケアの実態および薬剤師の役割の考察
Nov. 2022, [Reviewed] - Exploration of Trends in Antimicrobial Use and Their Determinants Based on Dispensing Information Collected from Pharmacies throughout Japan: A First Report
Yuichi Muraki; Masayuki Maeda; Ryo Inose; Koki Yoshimura; Naoki Onizuka; Masao Takahashi; Eiji Kawakami; Yoshiaki Shikamura; Naotaka Son; Makoto Iwashita; Manabu Suzuki; Masayuki Yokoi; Hirokazu Horikoshi; Yasuaki Aoki; Michiyo Kawana; Miwako Kamei; Hajime Hashiba; Choichiro Miyazaki
Antibiotics, 18 May 2022, [Reviewed]
The purpose of this study was to evaluate the defined daily doses (DDD)/1000 prescriptions/month (DPM) as a new indicator that can be used in pharmacies, and to describe antimicrobial use patterns in pharmacies nationwide in Japan. Dispensing volumes, number of prescriptions received, and facility information were obtained from 2638 pharmacies that participated in a survey. DPM was calculated based on the dispensing volume and number of prescriptions, which are routinely collected data that are simple to use. Use of third-generation cephalosporins, quinolones, and macrolides in pharmacies that received prescriptions primarily from hospitals or clinics decreased from January 2019 to January 2021. In particular, the antimicrobial use was higher in otorhinolaryngology departments than in other departments, despite a decrease in the antimicrobial use. In the linear multiple regression analysis, otorhinolaryngology department was independently associated with the third-generation cephalosporin, quinolone, and macrolide prescription in all periods. This study reveals for the first-time trends in antimicrobial use through a new indicator using the volume of drugs dispensed in pharmacies throughout Japan. Antimicrobial use differed by the medical department, suggesting the need to target interventions according to the department type. - What Should Pharmacists Do through the Clinical Research, toward the Community-based Integrated Care Systems? —From the Perspective of Dissemination and Implementation Research—
Miwako Kamei; Hiroshi Okada
YAKUGAKU ZASSHI, 01 Mar. 2022, [Reviewed], [Invited] - Components of the Collaboration between Hospital and Community Pharmacists in Municipal Hospitals: Findings from the Municipal Hospital Pharmacist Perspective Using Structural Equation Modeling
Kenji Takahashi; Rie Nakajima; Megumi Abe; Miwako Kamei; Fumiyuki Watanabe
Japanese Journal of Social Pharmacy, Dec. 2021, [Reviewed] - Factors Associated with Medication Non-Adherence among Patients with Lifestyle-Related Non-Communicable Diseases
Rie Nakajima; Fumiyuki Watanabe; Miwako Kamei
Pharmacy, 22 Apr. 2021, [Reviewed]
This cross-sectional study explored the association between medication non-adherence and its factors in patients with non-communicable diseases (NCDs) using an online structured questionnaire emailed to 30,000 people (aged over 20 years who lived in Japan at the time of the survey). The questions concerned respondents’ characteristics, medication non-adherence, health beliefs, lifestyles, and trouble taking medication. Factors related to non-adherence were analyzed among patients with lifestyle-related NCDs categorized into two age groups: 20–59, and >60 years. Unintentional (p < 0.001) and intentional (p < 0.001) non-adherence were more common among patients aged 20–59 than in older adults. NCD patients aged 20–59 experienced significantly more trouble taking medication than older adults. Multiple regression analysis showed that for patients aged 20–59 with NCDs, unintentional non-adherence was significantly and positively associated with current smoking habits (β = 0.280, p < 0.001), while intentional non-adherence was significantly and positively associated with alcohol consumption (β = 0.147, p = 0.020) and current smoking habits (β = 0.172, p = 0.007). In patients aged 20–59, unhealthy eating habits (β = −0.136, p = 0.034) and lack of exercise (β = −0.151, p = 0.020) were negatively associated with intentional non-adherence. In conclusion, factors affecting medication non-adherence in patients with lifestyle-related diseases are related to health awareness, lifestyle, and medication barriers. - 2型糖尿病患者における薬剤の服薬回数と服薬アドヒアランスおよび負担感-電子お薬手帳サービスを利用したインターネット・アンケート調査-
Sep. 2020, [Reviewed] - Economic Evaluation of Administration of Plerixafor Based on CD34 Positive Cell Measurement
Asami Funaki; Tatsuya Isezaki; Mariko Kawana; Ryohkan Funakoshi; Miwako Kamei
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 10 Jul. 2020, [Reviewed] - A Survey on Experience of Hospital Based Education Programs for Patients with Type 2 Diabetes in Japan
Yoshiro Okabe; Atsushi Ishimura; Fumiyuki Watanabe; Miwako Kamei
Jan. 2020, [Reviewed] - Conditions and Hardships Related to Pharmacists' Provisions of Anti-Doping Activities in Japan
Rie Nakajima; Naoko Onuma; Fumiyuki Watanabe; Miwako Kamei
International Journal of Sport and Health Science, 2020, [Reviewed] - Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients with Type 2 Diabetes
Ai Hayashi; Takekazu Kubo; Kotoba Okuyama; Shigeru Tokita; Miwako Kamei
YAKUGAKU ZASSHI, 01 Dec. 2019, [Reviewed] - NEW ROLE OF JAPANESE PHARMACISTS FOCUSING ON MEDICATION THERAPY MANAGEMENT IN A TEAM CARE APPROACH
Atsushi Kawahara; Kiyohito Nakai; Miwako Kamei
Journal of Pharmacy Practice and Research, 18 Sep. 2019, [Reviewed] - Trends in Study Design Assessment for Anti-Influenza Agents
Hisashi Iijima; Miwako Kamei
Japanese Journal of Pharmaceutical Health Care and Sciences, 10 Aug. 2019, [Reviewed] - Hospital–pharmacy cooperative training and drug-taking compliance in outpatients with chronic pain: a case–control study
Kentaro Uejima; Masatoshi Hayasaka; Jitsu Kato; Wakako Sakata; Susumu Ootsuka
Integrated Pharmacy Research and Practice, 02 Jul. 2019, [Reviewed] - Design and Implementation by Hospital Pharmacists of a Pharmacotherapy Management Protocol for Outpatients with Type-2 Diabetes
Atsushi Ishimura; Fumiyuki Watanabe; Munenori Fukui; Ruriko Suzuki; Miwako Kamei
The Journal of Community Pharmacy and Pharmaceutical Sciences, 17 May 2019, [Reviewed] - Validation of a reorganized training program using a cognitive behavioral therapy approach to enable community pharmacists to provide empathic patient counseling
Tanuma K; Watanabe F; Maeda H; Saitoh N; Kamei M
Yakugaku Zasshi, 01 Jan. 2019, [Reviewed] - How Type II Diabetes Outpatients Expect Hospital Pharmacists to be Involved
Atsushi Ishimura; Fumiyuki Watanabe; Munenori Fukui; Miwako Kamei
Japanese Journal of Pharmaceutical and Diabetes, 20 Dec. 2018, [Reviewed] - 年1回投与となるインクレチン関連薬のデバイスの開発
亀井 美和子
くすりと糖尿病, 20 Dec. 2018, [Invited] - Prescription surveillance for early detection system of emerging and reemerging infectious disease outbreaks
Tamie Sugawara; Yasushi Ohkusa; Hirokazu Kawanohara; Miwako Kamei
BioScience Trends., 01 Dec. 2018, [Reviewed] - Effect of the Routine Varicella Immunization on Herpes Zoster in Japan in the First Half of the Year
Tamie Sugawara; Yasushi Ohkusa; Miwako Kamei
Journal of Biosciences and Medicines, 16 Nov. 2018, [Reviewed] - Short Term Prediction of Infectious Diseases Patients from Prescription Surveillance
Tamie Sugawara; Yasushi Ohkusa; Hirokazu Kawanohara; Miwako Kamei
Journal of Biosciences and Medicines, 25 Sep. 2018, [Reviewed] - ひたちなか総合病院と近隣保険薬局におけるプロトコールに基づく薬物療法管理による残薬調整連携システム構築と成果
平井利幸; 渡邉文之; 寺門祐介; 篠原久仁子; 亀井美和子; 関利一
医療薬学, 10 Aug. 2018, [Reviewed] - Evaluation of new reimbursement fee for care of pharmacists in Japan
Kiyohito Nakai; Atsushi Kawahara; Miwako Kamei; Naomi Kurata
Pharmacy & Pharmacology International Journal, 09 Aug. 2018, [Reviewed] - Evaluation of the global action plan on antimicrobial resistance in Japan during its first eighteen months
Yasushi Ohkusa; Tamie Sugawara; Hirokazu Kawanohara; Miwako Kamei
Drug Discoveries & Therapeutics, 01 Jun. 2018, [Reviewed] - Welfare analysis of a zero-smoking policy - A case study in Japan
Yuuki Nakamura; Kenzo Takahashi; Marika Nomura; Miwako Kamei
Drug Discoveries & Therapeutics, 25 Feb. 2018, [Reviewed]
Smoking cessation efforts in Japan reduce smoking rates. A future zero-smoking policy would completely prohibit smoking (0% rate). We therefore analyzed the social welfare of smokers and non-smokers under a hypothetical zero-smoking policy. The demand curve for smoking from 1990 to 2014 was estimated by defining quantity as the number of cigarettes smoked and price as total tobacco sales/total cigarettes smoked by the two-stage least squares method using the tax on tobacco as the instrumental variable. In the estimation equation (calculated using the ordinary least squares method), the price of tobacco was the dependent variable and tobacco quantity the explanatory variable. The estimated constant was 31.90, the estimated coefficient of quantity was - 0.0061 (both, p < 0.0004), and the determinant coefficient was 0.9187. Thus, the 2015 consumer surplus was 1.08 trillion yen (US$ 9.82 billion) (95% confidence interval (CI), 889 billion yen (US$ 8.08 billion) - 1.27 trillion yen (US$ 11.6 billion)). Because tax revenue from tobacco in 2011 was 2.38 trillion yen (US$ 21.6 billion), the estimated deadweight loss if smoking were prohibited in 2014 was 3.31 trillion yen (US$ 30.2 billion) (95% CI, 3.13 trillion yen (US$ 28.5 billion) - 3.50 trillion yen (US$ 31.8 billion)), representing a deadweight loss about 0.6 trillion yen (US$ 5.45 billion) below the 2014 disease burden (4.10-4.12 trillion yen (US$ 37.3-37.5 billion)). We conclude that a zero-smoking policy would improve social welfare in Japan. - Comparative study of preciseness in the regional variation of influenza in Japan among the National Official Sentinel Surveillance of Infectious Diseases and the National Database of Electronic Medical Claims.
Yasushi Ohkusa; Tamie Sugawara; Kenzo Takahashi; Miwako Kamei
Bioscience trends, 2018, [Reviewed]
In Japan, national official surveillance for influenza has been performed at about 5,000 sentinel hospitals/clinics by the National Official Sentinel Surveillance of Infectious Diseases (NOSSID). Meanwhile, all electronic medical claims nationwide in the National Database of Electronic Medical Claims (NDBEMC) were recently disclosed by the Ministry of Health, Labour and Welfare of Japan. We compared the regional variation of influenza incidence among prefectures between the NOSSID and NDBEMC. The data were extracted from NOSSID and the NDBEMC for the 2010/2011 through 2013/2014 seasons. We compared the data of both datasets season by season by using Spearman's rank correlation in each season. Spearman's rank correlation values for the four seasons were 0.7823, 0.3907, 0.4961 and 0.4543, and their p-values were less than 0.00005, 0.0066, 0.0004 and 0.0013, respectively. Statistically, regional variation of influenza incidence in NOSSID is not imprecise, but its correlation with the NDBEMC dataset is not so high. It is important to note this fact when interpreting regional variation in NOSSID. - ケアマネージャーを対象とした在宅医療における薬局薬剤師業務の説明会の構築とその評価～ケアマネージャーの薬局薬剤師業務に対する認識と今後の期待～
渡邉 文之; 秦 千津子; 坂口 眞弓; 亀井 美和子
薬局薬学, 30 Sep. 2017, [Reviewed] - 「薬学教育研究」を始めるにあたって－基本的な心構え－
有田 悦子; 亀井 美和子
薬学教育, 05 Jul. 2017, [Invited] - 処方薬剤ごとの副作用の略字表示が服薬指導に与える影響－簡易情報提示システムの服薬支援ツールとしての効果の検証－
渡邉 文之; 山口 航; 鳥海 文歌; 佐谷 怜子; 亀井 美和子
薬局薬学, 30 Apr. 2017, [Reviewed] - Longitudinal Evaluation and Meta-analysis of Clinical Articles on the Antihypertensive Effects of Incretin-related Drugs
Hisashi Iijima; Miwako Kamei
Japanese Journal of Pharmaceutical Health Care and Sciences, 10 Apr. 2017, [Reviewed] - Development and Validation of a Training Program Using a Cognitive Behavioral Therapy Approach with the Purpose of Enabling Community Pharmacists to Provide Empathic Patient Counseling
Kazunori Tanuma; Fumiyuki Watanabe; Hatsuyo Maeda; Miki Shiina; Kazuo Hara; Miwako Kamei
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, Feb. 2017, [Reviewed] - 薬局薬剤師が心に寄り添う服薬支援をすることを目的とした認知行動療法的アプローチを用いた研修プログラムの開発と検証
田沼 和紀; 渡邉 文之; 前田 初代; 椎名 未貴; 原 和夫; 亀井 美和子
薬学雑誌, 01 Feb. 2017, [Reviewed] - 一般用医薬品の適正使用に貢献できる薬剤師育成のための卒後教育プログラムの構築とその効果
藤田吉明; 赤川(佐々木; 圭子; 小田中友紀; 平岡千英; 原和夫; 吉田武美; 亀井美和子; 木内祐二; 中村明弘; 山本俊憲
薬局薬学, 17 Oct. 2016, [Reviewed] - Assessment of Assistance in Smoking Cessation Therapy by Pharmacies in Collaboration with Medical Institutions - Implementation of a Collaborative Drug Therapy Management Protocol Based on a Written Agreement between Physicians and Pharmacists
Fumiyuki Watanabe; Kuniko Shinohara; Akira Dobashi; Kenji Amagai; Kazuo Hara; Kaori Kurata; Hideo Iizima; Kiyoshi Shimakawa; Masahiko Shimada; Sakurako Abe; Keiji Takei; Miwako Kamei
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, Sep. 2016, [Reviewed] - Community pharmacists provided telephone treatment support for patients who received long-term prescribed medication
Nobuo Yamamoto; Mitsuyo Nitta; Miwako Kamei; Kazuo Hara; Fumiyuki Watanabe; Keiko Akagawa; Naomi Kurata
Integrated Pharmacy Research and Practice, 30 Mar. 2016, [Reviewed] - 糖尿病領域における地域医療連携を目的とした薬剤師教育の取り組み～薬薬学連携への新たな試み～
石村淳; 渡邉文之; 田村久美; 根岸大輔; 鈴木康友; 亀井美和子
くすりと糖尿病, 20 Dec. 2015, [Reviewed] - Proposition of Real-time and Precise Prediction Model of Infectious Diseases Patients from Prescription Surveillance using National Database of Electronic Medical Claims
Yuuki Nakamura; Hirokazu Kawanohara; Miwako Kamei
Journal of Infection and Chemotherapy, 01 Oct. 2015, [Reviewed] - Current Situation and Future Possibilities of Drug Administration Guidance by Community Oharmacists for Patients to whom Antidepressants have been Prescribed
Fumiyuki Watanabe; Mao Sasaki; Miwako Kamei
Journal of Community Pharmacy and Pharmaceutical Sciences, 30 Sep. 2015, [Reviewed] - 米国のCDTMにおける訴訟リスク－ナースプラクティショナーの事例を踏まえて－
河原敦; 中井清人; 倉田なおみ; 亀井美和子
医療薬学, 10 Jun. 2015, [Reviewed] - 薬局サーベイランスを用いての水痘と帯状疱疹の患者数の関連に関する研究
中村裕樹; 川野原弘和; 亀井美和子
社会薬学, 10 Jun. 2015, [Reviewed]
Objective:Many epidemiological studies revealed that the varicella and herpes zoster have inverse correlation. This paper examines to confirm these associations by using Prescription Surveillance. Design: Multiple regression analysis about association between the incidence rate of herpes zoster and varicella adjusting for prefecture, fiscal year and week. Methods: We used the general public data from Prescription Surveillance. Prescription Surveillance estimates the number of patients who were prescribed anti-varicella zoster virus drug with age class. We assumed the patients under 15 years old were varicella patients, and over 65 years old were herpes zoster patients. Each the number of patient was aggregated by week and prefecture from April 5, 2010 to March 31, 2013. We regressed the incidence rate of herpes zoster on the incidence rate of varicella adjusting for prefecture, fiscal year and week. Moreover, we regressed it on the several lag of the incidence rate of varicella. Results: The incidence rate of varicella was significantly positive, however the estimated coefficient was 0.030. The lag of incidence rate of varicella were also significantly positive, however these estimated coefficient were less than 0.030. Conclusion: We found that the incidence rate of herpes zoster and varicella have positive correlation, however its magnitude was not so important. It needs attention that our finding means positive correlation when we remove seasonality and regionality of both incidences. - 薬局サーベイランスによる止瀉剤・整腸剤と下痢症の関連に関する検討
中村裕樹; 川野原弘和; 亀井美和子
感染症学雑誌, 01 May 2015, [Reviewed]
Object：It appears to be possible to measure the outbreak of infectious diseases with accompanying diarrhea by early detection of an outbreak. However, because some diseases are reported weekly from sentinel medical institutions, early detection of outbreaks might be inadequate. In this study, we examined the number of patients with diarrhea assessed with prescription surveillance and validated its association with the number of patients who have infectious diseases with diarrhea. Methods：The number of patients who were prescribed an antidiarrheal drug or intestinal drug was estimated for each prefecture using the prescription surveillance system from April 1, 2011 through March 31, 2014. Moreover, we examined the association between the prevalence of diarrhea in prescription surveillance and the number of patients with diarrheal infectious diseases. Results：Results showed a positive correlation between the prevalence of diarrhea in prescription surveillance and the number of reported cases per sentinel with gastrointestinal infections. However, no positive correlation was found with the others infectious diseases. Conclusion：Estimation of the number of patients with diarrhea in prescription surveillance might facilitate early detection of an outbreak of gastrointestinal infections. - 平成26年度日本大学学部連携研究推進シンポジウム「学部間協力による芸術学部標準模擬患者養成」
藤田之彦; 神山浩; 櫻井勇; 藤崎和彦; 井上千鹿子; 中阿地圭一郎; 穴澤万里子; 上原任; 中島一郎; 伊藤孝訓; 青木伸一郎; 亀井美和子; 渡邉文之
日本大学ＦＤ研究, 31 Mar. 2015 - 6年制薬学教育の学習成果「医療への貢献，社会への貢献：これから薬剤師としてどのように行動するか」～第3回全国学生ワークショップより～（誌上シンポジウム）
亀井美和子; 井元優美; 音羽亮; 志田美春; 平位祐実; 中村明弘
薬学雑誌, 01 Mar. 2015, [Reviewed], [Invited] - 学習成果基盤型教育に基づいて6年制薬学教育の学習成果を考える
中村 明弘; 長谷川 洋一; 亀井 美和子
YAKUGAKU ZASSHI, 01 Mar. 2015, [Reviewed], [Invited] - 全国医科電子レセプトを用いた薬局サーベイランスの都道府県別インフルエンザ推定患者数の評価
中村裕樹; 川野原弘和; 亀井美和子
厚生の指標, 01 Feb. 2015, [Reviewed] - 薬局サーベイランスによる水痘患者数推定の評価
中村裕樹; 川野原弘和; 亀井美和子
感染症学雑誌, 20 Jan. 2015, [Reviewed]
Object：It is important to know the precise number of varicella patients infected for evaluation of routine immunization and anti-bioterrorism attack using smallpox. Prescription Surveillance (PS) has been providing the estimated number of varicella patients up to the present. However, the estimated number of varicella patients cannot be validated because to date there has been no other comparable precise method of estimation. Recently, all electronic medical claims nationwide (NDB) have been disclosed. In this paper, we compare the number of varicella patients estimated by PS with NDB data, and adjust the number estimated with PS, if necessary. Method：For both NDB and PS, we used the monthly data from April, 2010 to March, 2013. The estimation of the number of varicella patients from the PS data was adjusted by the proportion of estimated number based on PS to the one based on NDB in the entire study period. Moreover, we adjusted it month by month, if the former method may not be enough to compensate for the discrepancy between the two data sets. Results：The average discrepancy between NDB and PS was 48.00％in three years. By the adjustment using NDB in the three years, the discrepancy was improved to 11.49％. However, seasonal patterns of overestimation or underestimation were found. Conversely, by the adjustment using NDB month by month, the discrepancy was greatly reduced to 4.33％. Moreover, the seasonal patterns of overestimation or underestimation disappeared. Conclusion：The number of patients based on NDB would appear the most precise number, however,there may be a delay of about one year before it becomes available. On the other hand, PS data are updated every day and provide us with the up-to-date situation. This paper found that combining the timeliness of the PS data and preciseness of the NDB data will provide substantial benefit for public health. - [Learning outcomes of six-year pharmaceutical education program].
Akihiro Nakamura; Yoichi Hasegawa; Miwako Kamei
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015 - [Outcome of the 6-year curriculum for pharmacy education: "Contribution to medical care and society: how will I act as a pharmacist in the future?"--A report on the 3rd National Student Workshop].
Miwako Kamei; Yumi Imoto; Ryo Otowa; Miharu Shida; Yumi Hirai; Akihiro Nakamura
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015
In August 2013, the Pharmaceutical Society of Japan held the Third National Student Workshop in Tokyo. A total of 88 people-70 sixth-year undergraduate students from 70 universities, and 18 alumni who had participated in the First and the Second Workshops-attended this Workshop. The theme of this Workshop was "Contribution to medical care and society: How will I act as a pharmacist in the future?" The first day took the form of a World Café, with participants exchanging information on such topics as, "The purpose for choosing a pharmacy major, and my achievement status", "My favorite aspects of my college", and "My dreams and paths: Painting my future image". Later that day, participants discussed and gave presentations on the ways they would be contributing as pharmacists to society and medical care. On the second day, participants discussed and gave presentations on the efforts they would like to make as pharmacists to contribute to society and medical care. The final session was a general assembly for discussion on the ways they would be contributing as pharmacists to society and medical care. Throughout the two days, attendees participated in discussions with an awareness of their common ground, in that they all had national qualification in spite of different intended paths. In this article, 4 sixth-year students (their status at the time of the symposium) from the Workshop introduce outlines of the discussions and products from each group. - Evaluation of Estimated Number of Influenza Patients from National Sentinel Surveillance Using the National Database of Electronic Medical Claims
Yuuki Nakamura; Tamie Sugawara; Hirokazu Kawanohara; Yasushi Ohkusa; Miwako Kamei; Kazunori Oishi
JAPANESE JOURNAL OF INFECTIOUS DISEASES, Jan. 2015, [Reviewed] - 糖尿病外来患者の残薬要因に応じた服薬指導の介入効果の検討
篠原久仁子; 大澄朋香; 笠原真奈美; 栗原元気; 佐竹正子; 松浦靖彦; 飯嶋秀郎; 高橋秀夫; 亀井美和子
くすりと糖尿病, 20 Dec. 2014, [Reviewed] - Diabetic Patients’ Perception of Zanyaku – Results from a Survey by the Japan Pharmaceutical and Diabetes Society
Tomoka Osumi; Kaori Yago; Mitsuko Tanaka; Masako Satake; Manami Kasahara; Kuniko Shinohara; Fumiyuki watanabe; Miwako kamei
Japanese Journal of Pharmaceutical and Diabetes, 20 Dec. 2014, [Reviewed]
Pharmaceutical management involves drugs left unused at the patients' homes (commonly called "zanyaku"). The definition of the term zanyaku, however, is not generally agreed upon. In this study, a survey was conducted on diabetic patients in an attempt to find out what they considered "zanyaku" to mean. We surveyed diabetic patients who visited healthcare institutions or pharmacies during the month of September 2013. Aggregate analysis was performed on the 209 responses collected. To the question "What is your impression when you hear the word zanyaku?" 55 respondents (32.4%, the highest rate) out of a total of 170 replied, "Necessary doses that I will use," followed by "Leftover doses exceeding a certain amount." (30.0%, 51 respondents). The results showed that individual patients had different ideas of what zanyaku meant. When managing zanyaku, pharmacists may need to collect information based on the patients' ability to self-manage drugs. - Proposal for Outcome Verification of “Iyakubungyo” and Future Directions
Miwako Kamei; Mitsuko Onda; Kazuko Akagi; Tomohide Akase; Noriko Fukushima; Noriko Miyamoto
Journal of Community Pharmacy and Pharmaceutical Sciences, 01 Apr. 2014, [Reviewed] - メタボリックシンドローム予防を目的とした生活習慣改善支援の効果
渡邉文之; 小森雄太; 木内祐二; 亀井美和子
日本予防医学会雑誌, 01 Dec. 2013, [Reviewed] - 医療機関と薬局との連携による糖尿病支援の実践とその効果について
篠原久仁子; 笠原真奈美; 飯嶋秀郎; 小沼真由美; 木内祐二; 亀井美和子
くすりと糖尿病, 15 Jun. 2013, [Reviewed] - セルフメディケーションの実践プロセス；感冒薬服用による排尿障害経験者を対象とした質的研究
赤川圭子; 関早苗; 中田亜希子; 小林靖奈; 亀井美和子; 山元俊憲
日本ファーマシューティカルコミュニケーション学会誌, 30 Apr. 2013, [Reviewed] - The relationship of Consumer Experiences and Expectations to the Role of the Community Pharmacy
Fumiyuki watanabe; Yuji Kiuchi; Miwako Kamei
The Journal of Community Pharmacy and Pharmaceutical Sciences, 31 Mar. 2012, [Reviewed] - Effects of combined olmesartan anti-hypertensive therapy and regular exercise on visceral fat mass, adipocyte size, and serum levels of lipid concentrations
西尾(西川; 絵梨子; 松原茂; 榛葉繁樹; 安川憲; 亀井美和子; 青山慎一郎; 森脇将光; 鈴木政登
桜門体育学研究, 30 Mar. 2012, [Reviewed] - Effects of a combination of exercise and caffeine intake on body fat mass and serym lipids concentrations
松原茂; 松尾(西川; 絵梨子; 榛葉繁樹; 安川憲; 亀井美和子; 鈴木政登
桜門体育学研究, 30 Mar. 2012, [Reviewed] - 電話による薬局における生活習慣の相談、指導実施に関する調査
岸本桂子; 福島紀子
医療薬学, 10 Jun. 2011, [Reviewed] - 長期投薬と保険薬局機能
薬局薬学, 31 Mar. 2011 - A Case Study on the Status of Pharmacies Assisting in the Treatment of Diabeted Mellitus through Community Relations
Kuniko Shinohara; Yukari Iso; Yoshiyuki Toshima; Yasunori Iijima
The Journal of Community Pharmacy and Pharmaceutical Sciences, 31 Mar. 2011, [Reviewed] - 睡眠改善薬に関する消費者の現状および販売時における薬剤師の関わり
佐々木圭子; 佐口健一; 大井浩明; 松本菜々; 三浦南虎; 真下順一; 齋藤勲; 向後麻里; 亀井美和子; 戸部敞
昭和大学薬学雑誌, Mar. 2011, [Reviewed] - Economic evaluation of services provided by pharmacists
Miwako Kamei
Japanese Journal of Clinical Pharmacology and Therapeutics, Nov. 2010 - 一般用医薬品の適正使用に貢献できる薬剤師育成のための卒後教育プログラムの構築とその効果
佐々木圭子; 藤田吉明; 小田中友紀; 原和夫; 中村明弘; 吉田武美; 亀井美和子; 戸部敞
医療薬学, Mar. 2010, [Reviewed] - 海外事情「イギリスの医療保険制度と薬局薬剤師に求められる役割」
日本薬剤師会雑誌2009年10月号, Oct. 2009 - Fluvoxamineによる社会不安障害治療の費用－効果分析
亀井美和子; 牧野剛仁
臨床精神薬理, Apr. 2009, [Reviewed] - The effect of one-dose package on medication adherence for the elderly care in Japan
Kiyohito Nakai; Nobuo Yamamoto; Miwako Kamei; Masahiko Fujita
Pharmacy Practice, 2009, [Reviewed] - 社会不安障害（SAD）の社会的コスト～労働損失額の推計と薬物治療の経済性について～
医薬ジャーナル, Jan. 2009 - 体重、血圧、内臓脂肪量および血清脂質に及ぼす運動と食事制限の比較
西川絵梨子; 松原茂; 榛葉繁樹; 渡邊雅紀; 安川憲; 亀井美和子; 鈴木政登
日本大学薬学部研究紀要, Jan. 2009, [Reviewed] - 壮年期の体重に及ぼす小児期における自発走運動の影響
松原茂; 西川絵梨子; 榛葉繁樹; 渡邊雅紀; 安川憲; 亀井美和子; 鈴木政登
日本大学薬学部研究紀要, Jan. 2009, [Reviewed] - Allocationg Health Care Resources: Japan Versus United States
Kiyohito Nakai; Nobuo Yamamoto; Masahiko Fujita; Miwako Kamei
DRUG BENEFIT TRENDS, Oct. 2008, [Reviewed] - Objective evaluation of generic-specific drug information
Hisashi Iijma; Toshimasa Koshimizu; Makoto Shiragami
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, [Reviewed] - OSCEトライアルの実施
倉田なおみ; 齋藤勲; 向後麻里; 真下順一; 佐野佳弘; 佐々木圭子; 亀井美和子; 戸部敞
都薬雑誌, Jan. 2007 - Contributions of pharmacists through the promotion of proper drug use
Yuya Ise; Mitsuko Onda; Yoshihiko Miura; Machiko Shimazaki; Keiko Kawada; Ken Hagiwara; Shirou Katayama; Arimichi Kikuchi; Miwako Kamei; Koji Kobayashi; Makoto Shiragami
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, [Reviewed] - 進行非小細胞肺癌における初回化学療法Carboplatin and Monthly Paclitaxel療法とCarboplatin and Weekly Paclitaxel療法の薬剤経済学的検討
成川仁之; 濃沼政美; 亀井美和子; 蝶名林直彦; 井上忠夫; 白神誠
医薬品情報学, May 2006, [Reviewed] - The realities and medical expense of hospitalization that originates in outpatient medicine treatment
Masayoshi Koinuma; Takahisa Yamanashi; Miwako Kamei; Makoto Shiragami
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, May 2006, [Reviewed] - HMG-CoA還元酵素阻害剤の薬剤経済学的検討
高橋努; 亀井美和子; 三枝良安; 滝本至得; 白神誠
医療薬学, Apr. 2006, [Reviewed]
Flat-sum payment systems for treatment costs, such as the Diagnosis Procedure Combination (DPC) system, are now being introduced in medical institutions. Owing to the introduction of such payment systems, hospital pharmacists are now required to be more actively involved in the selection of drugs through the provision of appropriate drug information including that on cost effectiveness. In Japan, however, very few pharmacoeconomic evaluations by hospital pharmacists have been reported to date. In view of this, we conducted a pharmacoeconomic evaluation of HMG-CoA reductase inhibitors using information that hospital pharmacists can obtain comparatively easily. Referring to an analytical method reported in Britain, we investigated the amounts of four kinds of HMG-CoA reductase inhibitors, Pravastatin, Simvastatin, Fluvastatin, and Atorvastatin, used for each strength in the target medical institutions. Responders to treatment was defined as patients whose lipid values (low density lipoprotein cholesterol and total cholesterol) improved to the level suggested in the 2002 edition of the Japan Atherosclerosis Society Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases. Based on this, we calculated response rates for the present investigation and other clinical studies conducted in Japan. Drug treatment costs were estimated based on the volume of the drugs administered and the drug prices listed in the National Health Insurance price list. The results of the current investigation showed that cost effectiveness was highest for atorvastatin followed by simvastatin, fluvastatin, and pravastatin. In addition, they indicated that based on treatment data available in their hospitals, hospital pharmacists are able to make practical pharmacoeconomic evaluations of drugs that reflect the actual practice of treatment. - マレイン酸メチルエルゴメトリンをコントロールとした芎帰調血飲の産褥管理における有用性のメタアナリシス
濃沼政美; 成川仁之; 亀井美和子; 白神誠
日本東洋医学雑誌, Jan. 2006, [Reviewed] - 業務量と患者満足度からみた一人薬剤師薬局における業務改善の問題点
山田健太郎; 亀井美和子; 白神誠
医療マネジメント学会誌, Dec. 2005, [Reviewed]
In June 2003, we assessed work volume of a one-pharmacist pharmacy by means of the work sampling method, and the content of the work performed by the pharmacist in each time period was then analyzed. A questionnaire survey of patients was conducted in July 2004, and the degree of satisfaction in each time period was analyzed. Results of the work volume measurement revealed that the bulk of prescriptions were concentrated in the morning hours, when the amount of discretionary time on the part of the pharmacist was extremely limited. Results also showed that the degree of patient satisfaction was low during this busy morning period. This drop in perceived level of service should be preventable by means of an improvement in ratings of waiting time and patient compliance instruction, which have been linked to patients' degree of satisfaction with pharmacy use. However, because it is difficult to reduce dispensing time when only one pharmacist in on duty, improvement of patient perception of service level will entail taking steps to improve the environment so as to mitigate the psychological distress of waiting. - 薬局における健康食品の取り扱い状況および調剤業務との関連性について
濃沼政美; 屋代詠子; 亀井美和子; 白神誠
医療薬学, Nov. 2005, [Reviewed]
We investigated the way that health foods (including those for specified health uses) are sold at pharmacies, awareness of interactions and the extent of information gathering when health foods are dispensed together with prescription drugs. To obtain data for our study, we sent a questionnaire by mail to 176 pharmacies belonging to the Chiba Pharmaceutical Association. The questionnaire asked for background information on pharmacies, and about how health foods are sold, the information given on them, awareness of interactions, information gathering methods and status of interactions in the case that health foods are dispensed together with prescription drugs. We next analyzed the results for a relationship between the dispensing status and methods of gathering information on interactions in the case of concomitant use of health foods and pharmaceutical products. In doing this, we investigated the independence among groups using the Wilcoxon rank sum test, specifying the average numbers of prescriptions dispensed per day and share of prescription drug sales as dependent variables, and whether or not information on interactions was sought using the internet or by making inquiries to pharmaceutical companies as explanatory variables. We received completed questionnaires from 77 pharmacies (response rate 43.7%). Based on their responses, the average monthly number of prescriptions per pharmacy was 1,738.9, dispensing accounted for 68% of sales, and the average manhours per day was 26.1 hours. The rate for conducting checks concerning health foods at the time of dispensing was 53.2%. As for the average number of prescriptions handled per day, we concluded that more inquiries were made to pharmaceutical companies as the number of prescriptions handled increased since there was a significant difference between the with and without inquiries to pharmaceutical companies groups (p=0.0037). - Evaluation of information for generic drugs based on importance and necessity
Hisashi Iijima; Miwako Kamei; Toshimasa Koshimizu; Makoto Shiragami
Yakugaku Zasshi, Sep. 2005, [Reviewed] - ジェネリック医薬品における重要度および必要度係数に基づく情報評価
飯嶋久志; 亀井美和子; 小清水敏昌; 白神誠
薬学雑誌, Sep. 2005, [Reviewed] - 薬局機能評価マニュアルに係る消費者アンケートの分析－薬局・薬剤師に対する意見の分析結果－
藤井康博; 亀井美和子; 濃沼政美; 白神誠
社会薬学, Jul. 2005, [Reviewed] - Feasibility study for the pharmacoeconomic analysis of Kampo medicines
Masayoshi Koinuma; Miwako Kamei; Kuniko Matsumoto; Misai Yagi; Makoto ShiragamiFeasibility
Kampo Medicine, May 2005, [Reviewed] - Pharmaceutical cost comparison analysis of antimicrobial use for surgical prophylaxis on gastrectomy patients in a tertiary care hospital
Y Ise; K Hagiwara; M Onda; M Kamei; S Katayama; K Nishizawa; M Hirano; T Kiyama
CHEMOTHERAPY, 2005, [Reviewed] - Objective evaluation of generic drug information
Hisashi Iijima; Miwako Kamei; Toshimasa Koshimizu; Makoto Shiragami
Yakugaku Zasshi, Jun. 2004, [Reviewed] - 医薬分業下での薬局薬剤師によるファーマシューティカル・ケアの便益の測定
亀井美和子; 伊藤里奈; 白神誠
医療薬学, Jan. 2004, [Reviewed]
The objective of this study was to determine whether the quality of pharmaceutical care provided under "iyaku bungyo" (separation of dispensing and prescribing functions) offsets the additional time and expense involved. The subjects of the study were 1,024 adults living in Tsurumi Ward, Yokohama. We surveyed their willingness to pay (WTP) in the pharmaceutical care setting, and then estimated benefits from the results obtained. Taking the patients' share of the total cost under the medical insurance scheme (co-payment) as the cost, we also performed a cost-benefit analysis (CBA). The responses of 182 people were used for the analysis of the survey results. The median for WTP was \200, and the mean was \297 (standard deviation : \309) and correlations between WTP and age of respondent, existence of a familiar pharmacy, and opinions regarding health care costs were observed. In the cost-benefit analysis which used the median for WTP as a reference, the benefit was greater than the cost for cases when the cost was set as the rate of co-payment of the current consultation fee (30%), but the benefit was less than the cost in cases in which the cost was a greater financial burden to patients than this as a result of iyaku bungyo. We found that WTP for pharmaceutical care under iyaku bungyo was not greatly influenced by the amount of the respondent's income. The fact that WTP was high for persons having a familiar pharmacy that they regularly visited suggests that the benefit may be higher when people are more satisfied with the pharmaceutical care they receive. Further studies of pharmaceutical care costs using cost-benefit analysis should be made in the future, and situation parameters further refined. - 地域住民の医薬分業に対する意識
亀井美和子; 白神誠
社会薬学, Jan. 2004, [Reviewed] - 外来慢性疾患患者の服薬コンプライアンスに関する研究－外来処方日数の制限廃止による影響に着目して
恩田光子; 亀井美和子
社会薬学, Jan. 2004, [Reviewed] - クリニカルパス適用胃切除患者におけるCefazolin（CEZ）とAmpicillin/Sulbactam（SBT/ABPC）の術後感染発症阻止効果に対する費用対効果分析
伊勢雄也; 萩原研; 齋藤節生; 本城和義; 宋静香; 加藤あゆみ; 片山志郎; 西澤健司; 平野公晟; 吉行俊郎; 木山輝郎; 三橋恭子; 亀井美和子; 白神誠
薬学雑誌, Jan. 2004, [Reviewed] - Valuing the drug information provided for generics in setting the price of generic drugs in Japan
H Iijima; T Kurosaki; M Kamei; T Koshimizu; M Shiragami
DRUG INFORMATION JOURNAL, 2004, [Reviewed] - HMG-CoA還元酵素阻害剤におけるジェネリック医薬品の情報量の評価
飯嶋久志; 亀井美和子; 小清水敏昌; 白神誠
医療薬学, Jan. 2004, [Reviewed]
The establishment in 2002 of additional remuneration for the use of branded generic drugs in medical treatment has led to an increase in their use. However, debate continues on various issues, a major one the availability of drug information (DI) on such products, since DI is such a vital component in all assessments of the safety and effectiveness of pharmaceuticals. We therefore conducted an objective evaluation of the adequacy of DI on branded generic forms of pravastatin sodium and simvastatin, using the media of drug package inserts and interview forms. On a scale setting the amount of DI provided for the original drugs at 100, the quantities of DI available for generic pravastatin sodium and simvastatin were 34.1±11.0% (Mean±SD) and 37.3±12.2% (Mean±SD), respectively. Comparison of the amounts of DI available at present with those at the time the original drugs first appeared on the market showed increases of 39.4% for pravastatin sodium and 47.1% for simvastatin. The branded generic forms of the drugs considered in this study have only recently become commercially available. So, information gained through experience of using such drugs in the clinical setting hereafter will be incorporated into future package inserts and interview forms, providing healthcare professionals with fuller descriptions of their uses, interactions, and adverse reactions. - 医療機関医薬品情報室における医薬品情報源の現状
飯嶋久志; 黒崎照代; 亀井美和子; 小清水敏昌; 白神誠
医薬品情報学, Jan. 2004, [Reviewed] - 新医薬品の解説「骨粗鬆症治療剤塩酸ラロキシフェン」
日薬医薬品情報, Jan. 2004 - DSU解説「精神神経用剤エチゾラムの添付文書の改訂」
日薬医薬品情報, Jan. 2004 - Calculation of drug information necessity factor of generic drugs
Hisashi Iijima; Teruyo Kurosaki; Miwako Kamei; Toshimasa Koshimizu; Makoto Shiragami
Yakugaku Zasshi, Dec. 2003, [Reviewed] - 米国の法規制からみたリフィルの仕組みと薬局薬剤師の役割
亀井美和子; 小柳津幸子; 恩田光子; 白神誠
社会薬学, Jan. 2003, [Reviewed] - ジェネリック医薬品における情報評価の必要度係数算出
飯嶋久志; 黒崎照代; 亀井美和子; 小清水敏昌; 白神誠
薬学雑誌, Jan. 2003, [Reviewed] - 新医薬品の解説「イベルメクチン」
日薬医薬品情報,, Jan. 2003 - 諸外国における薬剤経済ガイドラインの現状
日薬医薬品情報, Jan. 2002 - 新医薬品の解説「リン酸クリンダマイシンゲル」
日薬医薬品情報, Jan. 2002 - An exploration of pharmacist-initiated queries on problematic prescriptions in japanese community pharmacies
Makoto Shiragami; Miwako Kamei; Takeshi Nakamura
Journal of Research in Pharmaceutical Economics, 2001, [Reviewed] - Investigation of patients' demand for community pharmacies: Relationship between pharmacy services and patient satisfaction
M. Kamei; K. Teshima; N. Fukushima; T. Nakamura
Yakugaku Zasshi, 2001, [Reviewed] - ワークサンプリング法を用いた保険薬局の業務分析
亀井美和子; 黒崎照代; 中村健
日本薬剤師会雑誌, Jan. 2001 - Analysis of relationship between Community Pharmacies’ Work Situations and Time Required to Fill Prescription
Makoto Shiragami; Miwako Kamei; Noriko Fukushima; Takeshi Nakamura
shakai-yakugaku, Jan. 2000, [Reviewed] - 医療保険における調剤報酬の歴史的変遷とその考察（第２報）－調剤報酬の改定にみる行政施策の検証－
白神誠; 亀井美和子; 中村健
薬史学雑誌, Jan. 2000, [Reviewed] - 医療保険における調剤報酬の歴史的変遷とその考察（第１報）－健康保険法の成立と薬剤支給契約から調剤報酬の公定まで－
白神誠; 亀井美和子; 中村健
薬史学雑誌, Jan. 2000, [Reviewed] - Analysis of Relationship between Community Pharmasies' Work: Situations and Time Required to Fill Prescriptions
Makoto Shiragami; Miwako Kamei; Noriko Fukushima; Takeshi Nakamura
Japanese Journal of Social Pharmacy, Jan. 2000, [Reviewed] - Comparative analysis of pharmacy services based on newly developed evaluation index
Miwako Kamei; Kunikazu Teshima; Takeshi Nakamura
Yakugaku Zasshi, 2000, [Reviewed] - 米国におけるコミュニティ薬局の経営環境と評価要因の動向
都薬雑誌, Jan. 2000 - 処方せん確認業務の有用性の検証;医薬分業のリスクマネージメント機能の実証
亀井美和子; 菅沼太陽; 中村健
調剤と情報, Jan. 2000 - 平成10年度「疑義照会状況調査」の分析と評価
中村健; 亀井美和子; 菅沼太陽
日本薬剤師会雑誌, Jan. 1999 - 世界の薬学生、薬剤師と過ごしたロンドンの12日間
亀井美和子; 堀内正子
調剤と情報, Jan. 1999 - 薬剤師職能とかかりつけ薬局に対する認識
亀井美和子; 井上友貴; 中村健
調剤と情報, Jan. 1999 - 疑義照会状況調査結果の解説
中村健; 亀井美和子
臨床と薬物治療, Jan. 1999 - A Study on Consumers' Pharmacy Selection Factors in the USA
Miwako Kamei; Shizue Ochi; Takeshi Nakamura
The Japanese Journal of History of Pharmacy, Jan. 1998, [Reviewed] - A Survey and Critique of Consumer Perceptions for Community: Pharmacy in the USA during the 1970s-1990s
Miwako Kamei; Takeshi Nakamura
The Japanese Journal of History of Pharmacy, Jan. 1998, [Reviewed] - 患者の薬局選択要因と最近の動向;米国における薬局に対する患者の意識（第２報）
亀井美和子; 越智静江; 中村健
日本薬剤師会雑誌, Jan. 1998 - 処方せん確認業務の有用性とその実証
中村健; 亀井美和子; 井上友貴
日本薬剤師会雑誌, Jan. 1998 - 患者意識からみた薬局の経営理念の変遷1970-1990年代;米国における薬局に対する患者の意識（第１報）
亀井美和子; 中村健
日本薬剤師会雑誌, Jan. 1998 - 未成年男子大学生の喫煙行動・意識および知識の地域差，学部差，学年差および調査年代差
塩田正俊; 松原茂; 亀井美和子; 岩本圭史
日本公衆衛生雑誌, Jan. 1997, [Reviewed] - アメリカのコミュニティ薬局－現在の業務状況、問題点と将来の展望について－
Walter Mullen; 斎藤紀子; 亀井美和子; 水野善郎; 中村健
日本薬剤師会雑誌, Jan. 1997 - 患者意識調査からみた薬局に対するニーズの解析－患者インタビューによるケーススタディ－
亀井美和子; 中村健; 梅田富雄
厚生の指標, Jan. 1996, [Reviewed] - 保険薬局における調剤報酬の各種単位当たり金額とその動向;保険調剤における薬剤使用に関する調査研究(その７)
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1992 - 保険調剤における調剤報酬の内訳別構成比率とその動向;保険調剤における薬剤使用に関する調査研究(その６)
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1992 - 保険調剤における処方品目数からみた投薬動向;保険調剤における薬剤使用に関する調査研究(その５)
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1992 - 保険調剤の業務頻度の分析;保険調剤における薬剤使用に関する調査研究(その３)
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1992 - 保険調剤における新開発医薬品の使用状況;保険調剤における薬剤使用に関する調査研究,
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1992 - 使用医薬品の薬効分類別投薬状況;保険調剤における薬剤使用に関する調査研究(その２)
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1992 - 保険調剤における処方内容からみた使用医薬品の分析;保険調剤における薬剤使用に関する調査研究(その１)
中村健; 永喜美和子; 藤井正美
日本薬剤師会雑誌, Jan. 1991 - 投薬（外来患者）関連指標の年次推移とその考察
中村健; 永喜美和子; 藤井正美
厚生の指標, Jan. 1990, [Reviewed] - 薬局および患者を取り巻く環境と薬歴利用による各種処方鑑査結果との関連性
中村健; 永喜美和子; 台悦子; 藤井正美
薬剤学, Jan. 1989, [Reviewed] - 薬歴利用による処方鑑査結果とその有用性
中村健; 永喜美和子; 台悦子; 藤井正美
薬剤学, Jan. 1989, [Reviewed]
MISC
- 在宅緩和領域における薬薬連携を⽬的とした集団研修の傾向と効果の考察
上島健太郎; 早坂正敏; 坂田和佳子; 岸美智子; 吉田善一; 亀井美和子
緩和医療薬学雑誌, 22 Mar. 2019, [Reviewed] - 服薬アドヒアランスと患者支援
亀井 美和子
糖尿病の最新治療, 01 Jul. 2017, [Invited]
フジメディカル出版 - Welfare Analysis on Japan’s Smoke Zero Policy.
TAKAHASHI K; Nakamura Y; Nomura M; Kamei M
Proceedings of APACPH 2016, Sep. 2016, [Reviewed] - Influenza Question & Answer インフルエンザ患者数はどのように集計しているのでしょうか．
亀井美和子
インフルエンザ, 01 Jan. 2016, [Invited]
メディカルレビュー社 - 知っていそうで知らない薬価の決まり方
亀井美和子
月刊薬事, 01 Oct. 2015, [Invited]
じほう - 地域医療で求められる新たな薬局サービス～イギリスＮＨＳで提供されるＭＵＲとＭＡＳについて～
亀井美和子
medical forum CHUGAI, 18 Sep. 2015, [Invited] - 「健康ナビステーション」で輝く薬剤師になるために：セルフケアのサポート
亀井美和子
Alfresa Pharmacy News, 15 Sep. 2015, [Invited] - 「健康ナビステーション」で輝く薬剤師になるために：通院患者の薬物療法マネジメント
亀井美和子
Alfresa Pharmacy News, 15 Aug. 2015, [Invited] - 「健康ナビステーション」で輝く薬剤師になるために：患者の心の支援
亀井美和子
Alfresa Pharmacy News, 15 Jul. 2015, [Invited] - 「健康ナビステーション」で輝く薬剤師になるために：服薬アドヒアランス低下の理由と対処法
亀井美和子
Alfresa Pharmacy News, 15 Jun. 2015, [Invited] - 「健康ナビステーション」で輝く薬剤師になるために：在宅訪問の目的とは
亀井美和子
Alfresa Pharmacy News, 15 May 2015, [Invited] - 「健康ナビステーション」で輝く薬剤師になるために：残薬への関わり
亀井美和子
Alfresa Pharmacy News, 15 Apr. 2015, [Invited] - 糖尿病治療薬の処方実態を踏まえた薬剤師の関わり方の提案
秋山滋男; 香山重基; 岡部佳郎; 渡邉文之; 亀井美和子; 笠原真奈美; 篠原久仁子
くすりと糖尿病, Dec. 2014, [Reviewed] - 英国のジェネリックの薬価制度と普及のインセンティブ
亀井 美和子
月刊薬事 初収載ジェネリックガイド, 01 Jan. 2014
じほう - 医療機関と薬局との連携による糖尿病療養支援の実践とその効果について
篠原 久仁子; 笠原 真奈美; 菊池 聡; 飯嶋 秀郎; 小沼 真由美; 木内 祐二; 亀井 美和子
糖尿病, Apr. 2012
(一社)日本糖尿病学会 - 長期投薬患者への電話による治療支援の有用性
新田 光代; 山高 慎; 秋元 麻里; 原 和夫; 山本 信夫; 渡邉 文之; 木内 祐二; 亀井 美和子
日本薬学会年会要旨集, Mar. 2012
(公社)日本薬学会 - 地域薬局が提供する生活習慣改善支援サービスがかかりつけ要因に与える影響
渡邉 文之; 亀井 美和子; 木内 祐二; 濃沼 政美; 今別府 敏行; 杉山 祐里江; 小森 雄太
日本薬学会年会要旨集, Mar. 2012
(公社)日本薬学会 - 昭和大学における体系的なチーム医療学習カリキュラムの構築
木内 祐二; 中村 明弘; 亀井 美和子; 大井 浩明; 倉田 なおみ; 高木 康; 成島 道昭; 高宮 有介; 鈴木 雅隆; 片岡 竜太; 向井 美惠; 井上 美津子; 中村 雅典; 弘中 祥司; 馬谷原 光織; 下司 映一; 鈴木 久義; 佐藤 満; 入江 慎治; 田中 一正; 倉田 知光; 萩原 康夫
保健医療福祉連携, Mar. 2011
日本保健医療福祉連携教育学会 - 学生は医療系4学部連携PBLでいかに学ぶか? 3年生医学・歯学・薬学・保健医療学部連携PBLにおけるグループダイナミクス
片岡 竜太; 向井 美惠; 井上 美津子; 中村 雅典; 弘中 祥司; 馬谷原 光織; 高木 康; 成島 道昭; 高宮 有介; 鈴木 雅隆; 木内 祐二; 中村 明弘; 亀井 美和子; 大井 浩明; 倉田 なおみ; 下司 映一; 鈴木 久義; 佐藤 満; 入江 慎治; 田中 一正; 倉田 知光; 萩原 康夫
保健医療福祉連携, Mar. 2011
日本保健医療福祉連携教育学会 - 医療機関と薬局の連携による糖尿病治療支援の実践とその効果
笠原 真奈美; 篠原 久仁子; 菊池 聡; 飯嶋 秀郎; 小沼 真由美; 亀井 美和子; 木内 祐二
日本薬学会年会要旨集, Mar. 2011
(公社)日本薬学会 - 長期投薬患者に対する薬剤師の電話による治療支援の有用性評価
新田 光代; 原 和夫; 山本 信夫; 亀井 美和子; 木内 祐二; 原口 一広
日本薬学会年会要旨集, Mar. 2011
(公社)日本薬学会 - 睡眠改善薬に関する消費者の現状および販売時における薬剤師のかかわり
佐々木 圭子; 佐口 健一; 松本 菜々; 向後 麻里; 齋藤 勲; 真下 順一; 大井 浩明; 三浦 南虎; 亀井 美和子; 戸部 敞
昭和大学薬学雑誌, Dec. 2010
昭和大学薬学雑誌編集委員会 - 昭和大学薬学部における「薬-学連携プログラム」の取り組みとその評価
佐々木 圭子; 真下 順一; 渥美 聡孝; 小浜 孝士; 田中 佐知子; 小林 靖奈; 中村 明弘; 加藤 裕久; 木内 祐二; 亀井 美和子; 山元 俊憲
日本薬剤師会学術大会講演要旨集, Oct. 2010
(公社)日本薬剤師会 - 患者に適した規格・剤形への変更についての薬剤師および医師の意識
亀井 美和子; 佐々木 圭子; 今井 正紀; 杉本 修康; 田中 真由美; 戸部 敞
日本薬学会年会要旨集, Mar. 2010
(公社)日本薬学会 - 一般用医薬品の適正使用に貢献できる薬剤師育成のための卒後教育プログラムの構築とその効果
佐々木 圭子; 藤田 吉明; 小田中 友紀; 原 和夫; 中村 明弘; 吉田 武美; 亀井 美和子; 戸部 敞
日本薬学会年会要旨集, Mar. 2010
(公社)日本薬学会 - 質的研究法を用いた服薬アドヒアランス低下の要因に関する研究
大塚 岳; 佐々木 圭子; 亀井 美和子
社会薬学, Oct. 2009
日本社会薬学会 - 新たな薬学系大学院教育に向けた国際交流活性化
小林 文; 板部 洋之; 山岡 聖子; 亀井 大輔; 沼澤 聡; 柴沼 質子; 荒川 秀俊; 伊藤 喬; 亀井 美和子; 佐藤 均; 木内 祐二; 戸部 敞; 中村 明弘; 山元 俊憲
日本薬学会年会要旨集, Mar. 2009
(公社)日本薬学会 - 共感的態度を身につけることを目的とした「コミュニケーション・服薬説明実習」の主観的および客観的評価
佐々木 圭子; 神山 紀子; 真下 順一; 井手口 直子; 山元 俊憲; 亀井 美和子
日本薬学会年会要旨集, Mar. 2008
(公社)日本薬学会 - 糖尿病患者における健康食品の使用状況および薬剤師の関わり方
佐々木 圭子; 伊藤 大; 師尾 昂子; 渡辺 雅紀; 榛葉 繁紀; 手塚 俊勝; 松原 秀樹; 松原 茂; 安川 憲; 山元 俊憲; 亀井 美和子
社会薬学, Mar. 2008
日本社会薬学会 - 医療人GP「チーム医療の有用性を実感する参加型学習」の構築と実施
木内 祐二; 山元 俊憲; 戸部 敞; 中村 明弘; 伊藤 喬; 亀井 美和子; 倉田 なおみ; 大井 浩明; 高宮 良介; 高木 康; 中村 雅典; 片岡 竜太; 鈴木 久義; 田中 一正; 倉田 知光; 工藤 一郎
日本薬学会年会要旨集, Mar. 2008
(公社)日本薬学会 - チーム医療の有用性を実感する参加型学習 「福祉の現状を知る」
中村 明弘; 亀井 美和子; 倉田 なおみ; 真下 順一; 佐々木 圭子; 齋藤 勲; 高橋 伊津美; 戸部 敞; 木内 祐二
日本薬学会年会要旨集, Mar. 2008
(公社)日本薬学会 - チーム医療の有用性を実感する参加型実習 「診療の流れを知る」
倉田 なおみ; 亀井 美和子; 中村 明弘; 戸部 敞; 木内 祐二
日本薬学会年会要旨集, Mar. 2008
(公社)日本薬学会 - 販売制度改革に伴う睡眠改善薬(塩酸ジフェンヒドラミン)販売者の関わりについて
佐々木 圭子; 神山 紀子; 山元 俊憲; 亀井 美和子
中毒研究, Oct. 2007
(株)へるす出版 - 後発医薬品に対する消費者の需要分析
大林 千恵; 佐々木 圭子; 菅原 民枝; 大日 康史; 戸部 敞; 亀井 美和子
日本薬学会年会要旨集, Mar. 2007
(公社)日本薬学会 - WEBアンケートによる糖尿病患者の生活背景因子に関する調査
師尾 昂子; 佐々木 圭子; 手塚 雅勝; 安川 憲; 榛葉 繁紀; 松原 茂; 松原 秀樹; 渡辺 雅紀; 山元 俊憲; 亀井 美和子
日本薬学会年会要旨集, Mar. 2007
(公社)日本薬学会 - －医薬品の価格決定システム、後発医薬品の参入による影響、薬剤師の薬物療法への関わり等に関する比較研究－
Mar. 2006 - 進行性非小細胞肺癌における初回化学療法Carboplatin and Weekly PaclitaxelとCarboplatin and Monthly Paclitaxelの統計学的比較
成川 仁之; 蝶名林 直彦; 西村 直樹; 岸 潤; 内村 伸; 小野 宏; 渡部 一宏; 石丸 博雅; 高山 慎司; 井上 忠夫; 荒川 一郎; 濃沼 政美; 亀井 美和子; 白神 誠
日本薬学会年会要旨集, Mar. 2005
(公社)日本薬学会 - P-404 外来投薬日数の制限緩和による影響 : 患者の服薬状況に着目した考察
01 Sep. 2003 - P-384 米国の法規制からみたリフィルの実態と薬剤師の役割
24 Sep. 2002
Books and other publications
- 薬事法規・制度・倫理マニュアル
亀井美和子; 恩田光子; 浦山隆雄; 赤羽根秀宜, Joint work
南山堂, 01 Apr. 2019 - 基礎から学ぶ！行動科学 理論とその技法
日本ファーマシューティカルコミュニケーション学会, Others, 禁煙治療をサポートするアプローチ
薬事日報社, 18 Apr. 2018
9784840814263 - 超簡単論文作成ガイド
飯嶋久志ほか, Joint work
薬事日報社, 07 Apr. 2016 - スタンダード薬学シリーズⅡ薬学総論Ⅱ．薬学と社会
Joint editor
東京化学同人, 01 Apr. 2016 - スタンダード薬学シリーズⅡ薬学総論Ⅰ．薬剤師としての基本事項
Joint editor
東京化学同人, 01 Apr. 2015 - 医学大辞典
Others
南山堂, 10 Mar. 2015 - 図解医薬品情報学
折井孝男, Joint work, 医薬品と法律
南山堂, 20 Jan. 2014
9784525781637 - 薬剤師が知っておきたい法律・制度
白神誠; 大室弘美; 志村紀子; 早瀬幸俊; 藤原英俊; 八木直美, Joint work, 77-112
じほう, 20 Jun. 2011 - 医療・病院管理用語事典（新版）
濃沼信夫ほか, Joint work, 37, 70
市ヶ谷出版社, 10 Jan. 2011 - 諸外国の薬剤給付制度と動向
中村健他, Joint work
薬事日報社, May 2010 - 薬事関係法規・制度マニュアル
中村健他, Joint work
南山堂, Sep. 2009 - これからの社会薬学
福島紀子他, Joint work
南江堂, Apr. 2009 - 薬剤師のための薬剤経済学
Joint work
廣川書店, Mar. 2009 - 新しい医薬品管理
加賀谷肇他, Joint work
じほう, Oct. 2008 - NEW医薬品情報
岡野善郎他, Joint work
廣川書店, Mar. 2007 - スタンダード薬学シリーズ5環境と衛生
Joint work
東京化学同人, 26 Mar. 2006
薬剤疫学のSBOのみ - スタンダード薬学シリーズ9薬学と社会
日本薬学会編, Joint work
東京化学同人, Mar. 2006 - ファーマシューティカル・コミュニケーション基礎編
ファーマシューティカル; コミュニケーション研究会, Joint work
南山堂, Apr. 2005 - 薬剤師の疑義照会
漆畑稔監修, Joint work
エルゼビア・ジャパン, Oct. 2004 - ＤＰＣ時代の病院医薬品マネジメント
恩田光子他監修, Joint work
じほう, Apr. 2004 - 健康経済学
大日康史監修, Joint work
東洋経済新報社, Apr. 2003 - 日米欧の薬局と薬剤師
中村健監修, Joint work
じほう, Jul. 2001
Lectures, oral presentations, etc.
- バイオシミラーの経済的価値
日本ジェネリック医薬品学会バイオシミラー分科会セミナー, 09 Jul. 2011, 日本ジェネリック医薬品学会バイオシミラー分科会 - 薬剤管理がもたらすアウトカム
第2回薬剤ベネフィットマネジメント研究会, 29 Jun. 2011, 薬剤ベネフィットマネジメント研究会 - 教育講演「ＣＤＴＭと薬局薬剤師」
日本薬局管理学研究会第6回年会, 26 Jun. 2011 - シンポジウム２「地域医療における他職種連携」
第２回アプライド・セラピューティクス学会学術大会, 12 Jun. 2011 - 体重、血圧、内臓脂肪量および血清脂質に及ぼす運動と食事制限の比較
西川絵梨子; 松原茂; 榛葉繁紀; 安川憲; 亀井美和子; 小池勝也; 鈴木政登
日本薬学会第130年会, 31 Mar. 2011 - 体脂肪および血清資質レベルに及ぼす運動とカフェイン併用の影響
松原茂; 西川絵梨子; 榛葉繁紀; 安川憲; 亀井美和子; 小池勝也; 鈴木政登
日本薬学会第130年会, 31 Mar. 2011 - 医療機関と薬局の連携による糖尿病治療支援の実践とその効果
笠原真奈美; 篠原久仁子; 菊池聡; 飯嶋秀郎; 小沼真由美; 亀井美和子; 木内祐二
日本薬学会第130年会, 29 Mar. 2011 - 長期投薬患者に対する薬剤師の電話による治療支援の有用性評価
新田光代; 原和夫; 山本信夫; 亀井美和子; 木内祐二; 原口一広
日本薬学会第130年会, 29 Mar. 2011 - 地域連携をベースとしたヘルスサービス研究－喘息アウトカム研究の概要と結果－
第20回日本医療薬学会年会, 14 Nov. 2010 - 薬学教育の新たな取り組み「社会薬学の取り組み」
第54回日本薬学会関東支部大会, 02 Oct. 2010 - 諸外国の薬局事情
日本保険薬局協会経営機能評価委員会勉強会, 03 Sep. 2010, 日本保険薬局協会 - イギリスの薬剤給付制度
薬剤経済研究会, 06 Aug. 2010, 薬剤経済研究会
Research Themes
- 緊急避妊薬の薬局販売に備えた薬剤師研修用資材の作成
Oct. 2024 - Mar. 2025 - 切れ目のないポリファーマシー対策を提供するための薬剤師間の情報連携の推進に資する研究
Apr. 2023 - Mar. 2024 - オンライン服薬指導の実施事例の調査と適正な実施に資する薬剤師の資質 向上のための方策についての調査研究
Apr. 2022 - Mar. 2024 - 薬学生・薬剤師の「対人援助力」養成のための新しい実践的教育プログラムの構築
01 Apr. 2017 - 31 Mar. 2023 - Research of discommunication phenomena related to pharmacists - for the construction of educational programs on humanism
Grant-in-Aid for Scientific Research (C)
Kyoto Gakuen University
01 Apr. 2014 - 31 Mar. 2017
Knowledge of clinical psychology, psychiatry and ethics and cultivation of humanistic attitude are essential for the pharmacists as helping profession. This research tried to fix the educational contents and methods to make the pharmacists good clinicians by gathering practical data about discommunication phenomena related to pharmacists and researching foreign educational programs in Germany and United States.
Data revealed that Japanese pharmacists had encountered many kinds of discommunication phenomena and the needs for constructing enough educational programs for the pharmaceutical students and pharmacists were suggested. - 医療情報の収集および提供時におけるプライバシー保護の指標の検討
2007 - 2009 - The role of community pharmacists in medication adherence a qualitative study of factors affecting non-adherence
Grant-in-Aid for Scientific Research (C)
Showa University
2006 - 2007
Grounded theory based qualitative methodology was utilized to investigate aspects of non-adherence. Recruited 20 patients had a home-based in-depth interview. Interviews were designed to enable a detailed and holistic exploration of medication-related problems from participants' perspectives. Data were recorded and transcribed verbatim to allow qualitative analysis. Two broad categories of medication non-adherence which were examined in the information from within patients' mind such as experiences of side effects, asymptomatic illness- and in the information from outside such as information from their friends, information from the TV etc. These categories of non-adherence were concerns about side effects, cognitive, and lack of information or understanding. In addition, these categories provide a focus for interventions by community pharmacists to support patients in achieving optimal theory outcomes. They demonstrate the need for a comprehensive approach using in-depth interview. We have also conducted the analysis of patients' demand for generic drugs as a factor of non-adherence. The results of conjoint analysis suggested pharmacist' explanation was a primary factor affecting demands for generic drugs. - リフィル処方に関する規制および再調剤における薬剤師の役割に関する研究
2001 - 2002
■University education and qualification information
